News AstraZeneca partners Health2Sync on CKD digital support tool Taiwan-based digital health firm Health2Sync has added another big pharma company to the roster of clients for its patient support platform.
News Sanofi extends Health2Sync digital diabetes partnership to J... Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets.
News Health2Sync and Sanofi to digitally manage diabetes in Taiwa... Taiwan-based digital health firm Health2Sync has partnered with Sanofi to help patients manage symptoms of diabetes.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.